Propanc Biopharma
PPCB
4 hedge funds and large institutions have $71.5K invested in Propanc Biopharma in 2026 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 5 closing their positions.
47% more capital invested
Capital invested by funds: $48.7K → $71.5K (+$22.8K)
2.01% more ownership
Funds ownership: 0.09% → 2.1% (+2%)
33% less funds holding
Funds holding: 6 → 4 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$42.8K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$26.1K |
| 3 |
HF
HRT Financial
New York
|
+$22.1K |
| 4 |
CIAM
Caitong International Asset Management
Hong Kong
|
+$4 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$19.4K |
| 2 |
MG
Marex Group
London,
|
-$7.18K |
| 3 |
VF
Virtu Financial
New York
|
-$4K |
| 4 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
-$1.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$1.28K |
PPCB Hedge Fund Activity: Q2 2026 in Review
4 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Propanc Biopharma (PPCB) for Q2 2026, worth a combined $71.5K — up 47% from $48.7K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PPCB and 3 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Jane Street, adding an estimated $42.8K. The largest seller was UBS Group, exiting entirely with an estimated $19.4K sold.
- 4 institutional investors held Propanc Biopharma (PPCB) as of Q2 2026, down from 6 in Q1 2026.
- Funds reported $71.5K of Propanc Biopharma stock for Q2 2026, up 47% quarter-over-quarter.
- 3 funds opened new Propanc Biopharma positions in Q2 2026 and 5 closed out, a net change of -2 holders.
- The largest Propanc Biopharma buyer in Q2 2026 was Jane Street, an estimated $42.8K added.
- The largest Propanc Biopharma seller in Q2 2026 was UBS Group, an estimated $19.4K sold.
Based on aggregated 13F filings for Q2 2026.